We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia.
- Authors
Gadsby, Naomi J.; Russell, Clark D.; McHugh, Martin P.; Mark, Harriet; Morris, Andrew Conway; Laurenson, Ian F.; Hill, Adam T.; Templeton, Kate E.
- Abstract
Background. The frequent lack of a microbiological diagnosis in community-acquired pneumonia (CAP) impairs pathogendirected antimicrobial therapy. This study assessed the use of comprehensive multibacterial, multiviral molecular testing, including quantification, in adults hospitalized with CAP. Methods. Clinical and laboratory data were collected for 323 adults with radiologically-confirmed CAP admitted to 2 UK tertiary care hospitals. Sputum (96%) or endotracheal aspirate (4%) specimens were cultured as per routine practice and also tested with fast multiplex real-time polymerase-chain reaction (PCR) assays for 26 respiratory bacteria and viruses. Bacterial loads were also calculated for 8 bacterial pathogens. Appropriate pathogen-directed therapy was retrospectively assessed using national guidelines adapted for local antimicrobial susceptibility patterns. Results. Comprehensive molecular testing of single lower respiratory tract (LRT) specimens achieved pathogen detection in 87% of CAP patients compared with 39% with culture-based methods. Haemophilus influenzae and Streptococcus pneumoniae were the main agents detected, along with a wide variety of typical and atypical pathogens. Viruses were present in 30% of cases; 82% of these were codetections with bacteria. Most (85%) patients had received antimicrobials in the 72 hours before admission. Of these, 78% had a bacterial pathogen detected by PCR but only 32% were culture-positive (P < .0001). Molecular testing had the potential to enable de-escalation in number and/or spectrum of antimicrobials in 77% of patients. Conclusions. Comprehensive molecular testing significantly improves pathogen detection in CAP, particularly in antimicrobialexposed patients, and requires only a single LRT specimen. It also has the potential to enable early de-escalation from broadspectrum empirical antimicrobials to pathogen-directed therapy.
- Subjects
COMMUNITY-acquired pneumonia; ANTI-infective agents; TERTIARY care; PATHOGENIC microorganisms; SOCIAL conditions in Great Britain; TWENTY-first century; DIAGNOSIS
- Publication
Clinical Infectious Diseases, 2016, Vol 62, Issue 7, p817
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/civ1214